FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Aarti Drugs Buyback 2024 and Weizmann Buyback 2024.
Aarti Drugs Buyback 2024 is a Tender Offer buyback proposed to list at BSE, NSE while Weizmann Buyback 2024 is a Tender Offer proposed to list at BSE, NSE.
Aarti Drugs Ltd. | Weizmann Ltd. | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Logo | ||||||||||||||||||||
Type of Buyback | Tender Offer | Tender Offer | ||||||||||||||||||
Listing At | BSE, NSE | BSE, NSE | ||||||||||||||||||
Face Value | ₹10 per share | ₹10 per share | ||||||||||||||||||
Buyback Price | ₹900 per share | ₹160 per share | ||||||||||||||||||
Issue Size | 6,65,000 shares | 3,65,169 shares | ||||||||||||||||||
Issue Size (Amount) | ₹59.85 Crores | ₹5.84 Crores | ||||||||||||||||||
Buyback Ratio |
|
|
||||||||||||||||||
Registrar | Link Intime India Private Ltd | Bigshare Services Pvt Ltd | ||||||||||||||||||
Lead Managers | Inga Ventures Pvt Ltd | Saffron Capital Advisors Private Limited | ||||||||||||||||||
Necessity of the buyback | The Company is proposing the Buyback to service the equity more efficiently. Additionally, the Company’s management strives to increase equity shareholder's value and the Buyback would result in amongst other things:
|
The Buyback is being undertaken for the following reasons:
|
Aarti Drugs Buyback 2024 and Weizmann Buyback 2024 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Aarti Drugs Buyback 2024 Buyback record date is Sep 05, 2024. Weizmann Buyback 2024 Buyback record date is Aug 30, 2024.
Aarti Drugs Ltd. | Weizmann Ltd. | |
---|---|---|
Record Date | Sep 05, 2024 | Aug 30, 2024 |
Offer Open Date | Sep 11, 2024 | Sep 05, 2024 |
Offer Closure Date | Sep 19, 2024 | Sep 11, 2024 |
Last date for receipt of tender forms | Sep 19, 2024 | Sep 11, 2024 |
Finalisation of buyback | Sep 25, 2024 | Sep 17, 2024 |
Last Date for settlment of bids | Sep 26, 2024 | Sep 19, 2024 |
Last Date for extinguishment of shares | Oct 08, 2024 | Sep 30, 2024 |
Comparison of Aarti Drugs Buyback 2024 and Weizmann Buyback 2024 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.
Aarti Drugs Ltd. | Weizmann Ltd. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Aarti Drugs Ltd. Financial Information (Restated Consolidated)Aarti Drugs Ltd.'s revenue decreased by -7% and profit after tax (PAT) rose by 3% between the financial year ending with March 31, 2024 and March 31, 2023.
|
Weizmann Ltd. Financial Information (Restated Consolidated)Weizmann Ltd.'s revenue decreased by -8.93% and profit after tax (PAT) rose by 56.43% between the financial year ending with March 31, 2024 and March 31, 2023.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock price at BSE | Stock price at BSE (in preceding 3 months)
|
Stock price at BSE (in preceding 3 months)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock price at NSE | Stock price at NSE (in preceding 3 months)
|
Stock price at NSE (in preceding 3 months)
|
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|